Daily non-political popular news in brief.
Einstein scientists treat cancer as an infectious disease -- with promising results
10-30-2007 · EurekAlert!Researchers at the Albert Einstein College of Medicine of Yeshiva University have shown for the first time that cancers can be successfully treated by targeting the viruses that cause them. The findings, published in the Oct. 31 issue of PloS One, also raise the possibility of preventing cancer by destroying virus-infected cells before they turn cancerous.
Read more »
Keywords: einstein, scientists, treat, cancer, infectious, disease, promising, results, scientist, infectiou, result
« Previous | Next »
Similar news on "Einstein scientists treat cancer as an infectious disease -- with promising results":
- Cell receptor may lead to new 'biomarker' for pancreatic cancer
07-01-2007 · EurekAlert!
A research team led by University of Cincinnati scientists has identified a potential biological target for pancreatic cancer, a finding they say could help scientists better understand -- and eventually treat -- the disease that kills more than 33,000 people each year.
Similar news · Read more »
- Scientists gain important insights into acute promyelocytic leukemia
07-09-2007 · EurekAlert!
Results from two new studies provide key mechanistic insights into the complex molecular events that cause a deadly type of leukemia. The research, published in the July issue of the journal Cancer Cell, published by Cell Press, illuminates specific mechanisms involved in development of acute promyelocytic leukemia and identifies promising new avenues to develop treatments for some of its variant forms.
Similar news · Read more »
- Common cancer treatments toxic to healthy brain cells
11-29-2006 · EurekAlert!
Common drugs used to treat cancer may be more harmful to healthy brain cells than the cancer cells that they are intended to destroy, according to a new study. The results, which also indicate that chemotherapy may cause long-term brain damage, represent the closest that scientists have come to pinpointing the underlying physiological cause of "chemo brain," a common side effect of cancer treatment that scientists are only now beginning to comprehend.
Similar news · Read more »
- Enhanced environment restores memory in mice with neurodegeneration
04-29-2007 · EurekAlert!
Mice whose brains had lost a large number of neurons due to neurodegeneration regained long-term memories and the ability to learn after their surroundings were enriched with toys and other sensory stimuli, new studies have shown. The scientists were able to achieve the same results when they treated the mice with a specific type of drug that encourages neuronal growth. The studies suggest two promising avenues for treatments for neurodegenerative diseases such as Alzheimer's disease.
Similar news · Read more »
- Pancreatic cancer vaccine halts progression of disease in some patients
04-17-2007 · EurekAlert!
A dendritic cell-based therapeutic vaccine for pancreatic cancer developed by researchers at the University of Pittsburgh School of Medicine has successfully stalled the disease from progressing in a handful of patients three years post-vaccination. The results, part of a press briefing on cancer vaccines held at the annual meeting of the American Association of Cancer Research, provide promising evidence that the vaccine can trigger a patient's own immune system to rally against pancreatic cancer.
Similar news · Read more »
- Dasatinib, Nilotinib show strong early results as frontline therapy for chronic myelogenous leukemia
12-09-2007 · EurekAlert!
Two drugs approved for use as second line therapy for chronic myelogenous leukemia are showing promising results as frontline therapy for newly diagnosed patients in two clinical trials, research teams led by scientists at the University of Texas M. D. Anderson Cancer Center report at the 49th annual meeting of the American Society of Hematology.
Similar news · Read more »
- Genetic 'Roadmap' Charts Links Between Drugs And Human Disease
10-02-2006 · ScienceDaily
A research team led by scientists at the Broad Institute of MIT and Harvard developed a new kind of genetic "roadmap" that can connect human diseases with potential drugs to treat them, as well as predict how new drugs work in human cells. Called the "Connectivity Map," the tool and its uses are described in the September 29 issue of Science and in separate publications in the September 28 immediate early edition of Cancer Cell.
Similar news · Read more »
- Bacteria control how infectious they become, study finds
04-12-2007 · EurekAlert!
The results of a new study suggest that bacteria that cause diseases like bubonic plague and serious gastric illness can turn the genes that make them infectious on or off. Knowing how disease-causing bacteria, like Yersinia pestis and E. coli, do this may one day help scientists create drugs that control the expression of these genes, thereby making the bacteria harmless. The findings appear in the April 13 issue of the journal Molecular Cell.
Similar news · Read more »
- Systems Biology poised to revolutionize the understanding of cell function and disease
09-07-2007 · EurekAlert!
Systems Biology is transforming the way scientists think about biology and disease. This novel approach to research could prompt a shake up in medical science and it might ultimately allow clinicians to predict and treat complex diseases such as diabetes, heart failure, cancer and metabolic syndrome for which there are currently no cures.
Similar news · Read more »
- Innovative movies show real-time immune-cell activity within tumors
11-20-2006 · EurekAlert!
Using advanced new microscopy techniques in concert with sophisticated transgenic technologies, scientists have for the first time created three-dimensional, time-lapse movies showing immune cells targeting cancer cells in live tumor tissues. Immune cells called T cells can be seen actively migrating though tissues, making direct contact with tumor cells, and killing them. Insights from this new view of the body's on-board defenses against cancer may open the way for improved immunotherapies to treat the disease.
Similar news · Read more »
